Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAtara Biotherapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2026 | 3 | -$0.76 | $0.10 | -$0.25 |
| Q3 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2026 | 1 | $0.04 | $0.04 | $0.04 |
Atara Biotherapeutics Inc Earnings Date And Information
Atara Biotherapeutics Inc last posted its earnings results on Monday, March 16th, 2026. The company reported $-0.25 earnings per share for the quarter, missing analysts' consensus estimates of $-0.09 by $0.16. The company had revenue of 0 for the quarter and had revenue of 120.77 M for the year. Atara Biotherapeutics Inc has generated $3 earnings per share over the last year ($2.57 diluted earnings per share) and currently has a price-to-earnings ratio of -14.59. Atara Biotherapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Atara Biotherapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | N/A | -$0.29 | N/A | $2.90 M | $0 |
| 03/16/2026 | Q4 2025 | -$0.09 | -$0.25 | -0.16 | $3.37 M | $1.60 M |
| 11/12/2025 | Q3 2025 | -$0.83 | -$0.32 | 0.51 | $3.73 M | $3.45 M |
| 08/11/2025 | Q2 2025 | -$0.32 | $0.20 | 0.52 | $7.35 M | $17.58 M |
| 05/15/2025 | Q1 2025 | -$3.07 | $3.53 | 6.6 | $5.67 M | $98.15 M |
| 03/07/2025 | Q4 2024 | -$3.82 | -$1.19 | 2.63 | $20.58 M | $32.75 M |
| 11/12/2024 | Q3 2024 | -$3.77 | -$2.93 | 0.84 | $28.66 M | $40.19 M |
| 08/12/2024 | Q2 2024 | -$1.25 | -$3.10 | -1.85 | $37.09 M | $28.64 M |
| 05/09/2024 | Q1 2024 | -$9.25 | -$5.65 | 3.6 | $24.69 M | $27.36 M |
| 03/28/2024 | Q4 2023 | -$15.25 | -$13.98 | 1.27 | N/A | $4.25 M |
| 11/01/2023 | Q3 2023 | -$15.75 | -$16.40 | -0.65 | N/A | $2.14 M |
| 08/08/2023 | Q2 2023 | -$16.25 | -$16.91 | -0.66 | N/A | $957.00 K |
| 05/08/2023 | Q1 2023 | -$10.00 | -$17.98 | -7.98 | N/A | $1.23 M |
| 02/08/2023 | Q4 2022 | -$15.25 | -$18.07 | -2.82 | N/A | $221.00 K |
| 11/08/2022 | Q3 2022 | -$19.50 | -$20.53 | -1.03 | N/A | $4.46 M |
| 08/08/2022 | Q2 2022 | -$22.75 | $4.54 | 27.29 | N/A | $51.58 M |
| 05/05/2022 | Q1 2022 | -$24.50 | -$21.87 | 2.63 | N/A | $7.31 M |
| 02/28/2022 | Q4 2021 | -$15.00 | -$23.96 | -8.96 | N/A | $7.55 M |
| 11/04/2021 | Q3 2021 | -$23.00 | -$22.61 | 0.39 | N/A | $5.37 M |
| 08/09/2021 | Q2 2021 | -$22.00 | -$22.73 | -0.73 | N/A | $3.87 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Atara Biotherapeutics Inc Earnings: FAQ's
The conference call for Atara Biotherapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Atara Biotherapeutics Inc's latest earnings report can be read online.
Atara Biotherapeutics Inc (:ATRA) has a recorded annual revenue of $120.77 M.
Atara Biotherapeutics Inc (:ATRA) has a recorded net income of $32.69 M.Atara Biotherapeutics Inc has generated $2.61 earnings per share over the last four quarters.
Atara Biotherapeutics Inc (:ATRA) has a price-to-earnings ratio of -14.59 and price/earnings-to-growth ratio is 0.03.